COPD and systemic inflammation. A link for comorbidity;EPOC e inflamación sistémica. Una vía de enlace para la comorbilidad

Archivos de Bronconeumologia

Volumn 45, Issue SUPPL.5, 2009, Pages 14-17

  Agustí, Alvar ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Chronic bronchitis; Chronic diseases; Pulmonary emphysema

Indexed keywords

GLUCOCORTICOID;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE ASSOCIATION; HEALTH STATUS; HUMAN; INFLAMMATION; PREVALENCE; PROGNOSIS;

HUMANS; INFLAMMATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 72149133718     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(09)72858-3     Document Type: Article

References (29)

1. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 (2007) 532-555
2. Agusti A. Systemic Effects of Chronic Obstructive Pulmonary Disease: What We Know and What We Don't Know (but Should). Proceedings of the American Thoracic Society (2007) 522-525 4
3. Agusti A.G., Noguera A., Sauleda J., Sala E., Pons J., and Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21 (2003) 347-360
4. De Martinis M., Franceschi C., Monti D., and Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 579 (2005) 2035-2039
5. Gan W.Q., Man S.F., Senthilselvan A., and Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59 (2004) 574-580
6. Noguera A., Busquets X., Sauleda J., Villaverde J.M., MacNee W., and Agusti A.G. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 (1998) 1664-1668
7. Noguera A., Batle S., Miralles C., Iglesias J., Busquets X., MacNee W., et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 56 (2001) 432-437
8. Sauleda J., Garcia-Palmer F.J., Gonzalez G., Palou A., and Agusti A.G. The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease, asthma, and chronic arthritis. Am J Respir Crit Care Med 161 (2000) 32-35
9. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2 (2005) 50-60
10. Kim B.J., Yu Y.M., Kim E.N., Chung Y.E., Koh J.M., and Kim G.S. Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women. Clin Endocrinol (Oxf) 67 (2007) 152-158
11. Broekhuizen R., Wouters E.F.M., Creutzberg E.C., and Schols A.M.W.J. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61 (2006) 17-22
12. Broekhuizen R., Wouters E.F., Creutzberg E.C., and Schols A.M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61 (2006) 17-22
13. Koh J.M., Khang Y.H., Jung C.H., Bae S., Kim D.J., Chung Y.E., and Kim G.S. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 16 (2005) 1263-1271
14. Albert M.A., Danielson E., Rifai N., and Ridker P.M. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 286 (2001) 64-70
15. Vernooy J.H., Kucukaycan M., Jacobs J.A., Chavannes N.H., Buurman W.A., Dentener M.A., et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 166 (2002) 1218-1224
16. Yanbaeva D.G., Dentener M.A., Creutzberg E.C., Wesseling G., and Wouters E.F. Systemic effects of smoking. Chest 131 (2007) 1557-1566
17. Vassilakopoulos T., Roussos C., and Zakynthinos S. The immune response to resistive breathing. Eur Respir J 24 (2004) 1033-1043
18. Casadevall C., Coronell C., Ramirez-Sarmiento A.L., Martinez-Llorens J., Barreiro E., Orozco-Levi M., et al. Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients. Eur Respir J 30 (2007) 701-707
19. Rabinovich R.A., Figueras M., Ardite E., Carbo N., Troosters T., Filella X., et al. Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J 21 (2003) 789-794
20. Agusti A., Morla M., Sauleda J., Saus C., and Busquets X. NF-KB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 59 (2004) 483-487
21. Takabatake N., Nakamura H., Abe S., Inoue S., Hino T., Saito H., et al. Tomoike. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 (2000) 1179-1184
22. Van Eeden S.F., and Hogg J.C. The response of human bone marrow to chronic cigarette smoking. Eur Respir J 15 (2000) 915-921
23. Cosio M., Saetta M., and Agustí A. Immunological aspects of COPD. N Eng J Med 360 (2009) 2445-2454
24. Lee S.H., Goswami S., Grudo A., Song L.Z., Bandi V., Goodnight-White S., et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 13 (2007) 567-569
25. Rennard S.I., Fogarty C., Kelsen S., Long W., Ramsdell J., Allison J., et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175 (2007) 926-934
26. Vestbo J., Anderson W., Coxson H.O., Crim C., Dawber F., Edwards L., et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 31 (2008) 869-873
27. Morla M., Busquets X., Pons J., Sauleda J., MacNee W., and Agusti A.G. Telomere shortening in smokers with and without COPD. Eur Respir J 27 (2006) 525-528
28. Sin D.D., Man S.F.P., Marciniuk D.D., Ford G., FitzGerald M., Wong E., et al. The Effects of Fluticasone with or without Salmeterol on Systemic Biomarkers of Inflammation in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 177 (2008) 1207-1214
29. Sims M.W., Tal-Singer R.M., Kierstein S., Musani A.I., Beers M.F., Panettieri Jr. R.A., et al. Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study. Respir Res 9 (2008) 13